• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预防性偏头痛试验所需的患者数量。

Patient numbers needed in prophylactic migraine trials.

作者信息

Tfelt-Hansen P, Nielsen S L

机构信息

Department of Neurology, Københavns Amtssygehus i Gentofte, Hellerup, Denmark.

出版信息

Neuroepidemiology. 1987;6(4):214-9. doi: 10.1159/000110122.

DOI:10.1159/000110122
PMID:3683716
Abstract

Based on a multicenter double-blind crossover prophylactic migraine trial (n = 96), the relative effectiveness of the crossover design versus group comparison was evaluated. If a 'time effect' is taken into account in the statistical model, the crossover design was estimated to be 10-11 times more effective than the group comparison. With more traditional statistical methods using paired and unpaired t tests, the crossover design was estimated to be 4 times more powerful than the group comparison. Based on the t test, sample size tables for numbers of patients needed for detecting effect differences from 10 to 50% with powers from 0.6 to 0.9 in a crossover and a group comparison are presented. These calculations are based on only one trial, and it is recommended that similar estimations of sample variability should be done in other previous trials.

摘要

基于一项多中心双盲交叉预防性偏头痛试验(n = 96),对交叉设计与组间比较的相对有效性进行了评估。如果在统计模型中考虑“时间效应”,交叉设计的有效性估计比组间比较高10至11倍。使用配对和非配对t检验等更传统的统计方法,交叉设计的效能估计比组间比较高4倍。基于t检验,给出了在交叉设计和组间比较中,检测10%至50%效应差异且效能为0.6至0.9时所需患者数量的样本量表。这些计算仅基于一项试验,建议在其他先前的试验中进行类似的样本变异性估计。

相似文献

1
Patient numbers needed in prophylactic migraine trials.预防性偏头痛试验所需的患者数量。
Neuroepidemiology. 1987;6(4):214-9. doi: 10.1159/000110122.
2
Methodology of drug trials in migraine.偏头痛药物试验方法学
Funct Neurol. 1986 Oct-Dec;1(4):499-502.
3
Methodological aspects of drug trials in migraine.偏头痛药物试验的方法学方面
Neuroepidemiology. 1985;4(4):204-26. doi: 10.1159/000110232.
4
Methodological aspects of prophylactic drug trials in migraine.偏头痛预防性药物试验的方法学方面
Cephalalgia. 1981 Sep;1(3):127-41. doi: 10.1046/j.1468-2982.1981.0103127.x.
5
Migraine trials: crossover or parallel group?偏头痛试验:交叉设计还是平行组设计?
Neuroepidemiology. 1987;6(4):198-208. doi: 10.1159/000110120.
6
Efficacy of beta-blockers in migraine. A critical review.
Cephalalgia. 1986;6 Suppl 5:15-24. doi: 10.1177/03331024860060S502.
7
Clinical trials in migraine: parallel versus crossover studies.
Neuroepidemiology. 1987;6(4):209-13. doi: 10.1159/000110121.
8
[Methodology of clinical trials in migraine: a rating system].
Pathol Biol (Paris). 1992 Apr;40(4):361-6.
9
Dihydroergotamine nasal spray during migraine attacks. A double-blind crossover study with placebo.
Cephalalgia. 1987 Jun;7(2):131-3. doi: 10.1046/j.1468-2982.1987.0702131.x.
10
[Controlled therapeutic trials in migraine: methodology and results].[偏头痛的对照治疗试验:方法与结果]
Rev Neurol (Paris). 1982;138(4):279-95.

引用本文的文献

1
The crossover design for migraine preventives: an analyses of four randomized placebo-controlled trials.偏头痛预防药物的交叉设计:四项随机安慰剂对照试验分析。
J Headache Pain. 2019 Dec 27;20(1):119. doi: 10.1186/s10194-019-1067-z.
2
Feverfew for preventing migraine.小白菊用于预防偏头痛。
Cochrane Database Syst Rev. 2015 Apr 20;4(4):CD002286. doi: 10.1002/14651858.CD002286.pub3.
3
Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer.癌症患者中使用标准化剂量小白菊内酯的小白菊I期剂量递增试验。
Invest New Drugs. 2004 Aug;22(3):299-305. doi: 10.1023/B:DRUG.0000026256.38560.be.